Lazard Capital Downgrades Transcept Pharmaceuticals (TSPT) to Hold
Tweet
Share
E-mailGet Alerts TSPT Hot Sheet
Price: $1.70 --0%
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 15 | New: 9
Join SI Premium – FREE
Lazard Capital downgraded Transcept Pharmaceuticals (NASDAQ: TSPT) from Buy to Hold.
For more ratings news on Transcept Pharmaceuticals click here and for the rating history of Transcept Pharmaceuticals click here.
Shares of Transcept Pharmaceuticals closed at $4.87 yesterday.
For more ratings news on Transcept Pharmaceuticals click here and for the rating history of Transcept Pharmaceuticals click here.
Shares of Transcept Pharmaceuticals closed at $4.87 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Double Downgrades Mosaic (MOS) to Sell
- Cantor Fitzgerald Downgrades Monopar Therapeutics (MNPR) to Neutral
- Axis Capital Limited Downgrades National Aluminium (NACL:IN) to Sell (4)
Create E-mail Alert Related Categories
DowngradesRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
